The 2023 update of the EULAR recommendations for the management of systemic lupus erythematosus (SLE) recommend hydroxychloroquine (HCQ) for all patients with SLE at a target dose of 5 mg/kg real body weight (RBW)/day but also suggest individualizing the regimen in accordance with the risk of flares or retinal toxicity ...
The updated recommendations provide consensus guidance on the management of SLE, combining evidence and expert opinion. |
EULAR 2023 Recommendations for the Management of Systemic Lupus Erythematosus: One Step Forward · GLUCOCORTICOIDS: ENVISIONING THEIR USE AS BRIDGING THERAPY. |
13 окт. 2023 г. · The 2023 updates provide 5 overarching principles and 13 recommendations to guide physicians treating lupus around the world. |
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the Rheumatic Diseases Published Online First: 12 October 2023. |
The 2023 EULAR update recommends that treatment for LN should be continued for at least 3 years [1]. The BLISS-LN trial followed patients for 104 weeks, while ... |
16 янв. 2024 г. · An international task force has updated the EULAR recommendations for SLE management based on new evidence and emerging therapies. |
This paper has no abstract. Cite this article as: EULAR 2023 Recommendations for the Management of Systemic Lupus Erythematosus: One Step Forward. |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |